Florida legislation · 2026 Regular Session
Florida H1281: Prohibitions Against Discriminatory Practices relating to 340B Entities and 340B Drugs
Status: Failed, March 13, 2026
Prohibits drug manufacturers from engaging in certain acts against acquisitions of 340B drugs by & delivery of such drugs to specified pharmacies & from interfering with pharmacies' rights to contract with 340B entities; prohibits health insurance issuers, PBMs & other third-party payors, & agents, from engaging in discriminatory acts relating to reimbursement to 340B entities for 340B drugs; prohibits health insurers & HMOs from engaging in discriminatory acts relating to reimbursement to 340B entities for 340B drugs; provides that each commission of certain acts constitutes violation of Florida Deceptive & Unfair Trade Practices Act & subjects violator to certain actions & penalties.
What the bill says
An act relating to prohibitions against discriminatory practices relating to 340B entities and 340B drugs; providing a short title; creating s. 499.061, F.S.; providing definitions; prohibiting drug manufacturers from engaging in certain acts against the acquisitions of 340B drugs by and the delivery of such drugs to specified pharmacies; providing an exception; prohibiting drug manufacturers from interfering with pharmacies' rights to contract with 340B entities…
From the introduced text, January 8, 2026:
An act relating to prohibitions against discriminatory practices relating to 340B entities and 340B drugs; providing a short title; creating s. 499.061, F.S.; providing definitions; prohibiting drug manufacturers from engaging in certain acts against the acquisitions of 340B drugs by and the delivery of such drugs to specified pharmacies; providing an exception; prohibiting drug manufacturers from interfering with pharmacies' rights to contract with 340B entities; providing that each commission of certain acts constitutes a violation of the Florida Deceptive and Unfair Trade Practices Act and subjects the violator to certain actions and penalties; providing construction and applicability; creating s. 626.8829, F.S.; providing definitions; prohibiting health insurance issuers, pharmacy benefit managers, and other third-party payors, and agents thereof, from engaging in certain discriminatory acts relating to reimbursement to 340B entities for 340B drugs; providing applicability; providing that each commission of certain acts constitutes a violation of the Florida Deceptive and Unfair Trade Practices Act and subjects the violator to certain actions and penalties; providing construction; creating ss. HB 1281 2026 CODING: Words stricken are deletions; words underlined are additions. hb1281-00 Page 2 of FLORIDAHOUSEOFREPRESENTATIVES 627.64743, 627.65733, and 641.31543, F.S.; providing definitions; prohibiting individual health insurers, group, blanket, and franchise health insurers, and health maintenance organizations, respectively, and pharmacy benefit managers on behalf of these insurers and health maintenance organizations, from engaging …
Sponsors
- Franklin, Gallop (D, HD-008) · primary sponsor
- Franklin (D, 8) · primary sponsor
Latest actions
- : Died in Health Care Facilities & Systems Subcommittee
- : Now in Health Care Facilities & Systems Subcommittee
- : Referred to Health & Human Services Committee
- : Referred to Insurance & Banking Subcommittee
- : Referred to Health Care Facilities & Systems Subcommittee
- : 1st Reading (Original Filed Version)
- : Filed
Common questions
- What is H1281?
- H1281 is a bill in the Florida Legislature (2026 Regular Session): Prohibitions Against Discriminatory Practices relating to 340B Entities and 340B Drugs.
- What does H1281 do?
- In its own words: An act relating to prohibitions against discriminatory practices relating to 340B entities and 340B drugs; providing a short title; creating s. 499.061, F.S.; providing definitions; prohibiting drug manufacturers from engaging in certain acts against the acquisitions of 340B drugs by and the delivery of such drugs to specified pharmacies; providing an exception; prohibiting drug manufacturers from interfering with pharmacies' rights to contract with 340B entities…
- What is the status of H1281?
- Failed as of March 13, 2026. Latest action: Died in Health Care Facilities & Systems Subcommittee (March 13, 2026).
- Who sponsored H1281?
- Franklin, Gallop (D, HD-008), with 1 co-sponsor.
- Where is the official record for H1281?
- On the Florida Legislature website: https://www.flsenate.gov/Session/Bill/2026/1281
Source: official Florida record. Tracked by Delilah, AI for legislation across all 50 states and Congress.